Skip to content

Laser Cataract Surgery With the Femtosecond Laser Technology

Laser Cataract Surgery With the Femtosecond Laser Technology

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01382823
Enrollment
10
Registered
2011-06-27
Start date
2010-09-30
Completion date
2011-09-30
Last updated
2011-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataracts

Brief summary

The purpose of this study is to prove the efficacy and safety of the Femtosecond laser to create a clear corneal incision during cataract surgery.

Interventions

Using the Femtosecond Laser to make a clear corneal incision.

Sponsors

Innovative Medical
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Study participants must have a cataract for which phacoemulsification extraction and posterior IOL implantation has been planned in at least one eye. * Study participants should be capable of achieving better than 20/30 Snellen best corrected distance vision after cataract extraction and IOL implantation. * The surgeon may use the Mento Potential Acuity Meter (PAM)laser interferometer, McIntyre Pinhole, or his/her judgement to estimate the patient's potential acuity.

Exclusion criteria

* Concurrent participation or participation in the last 30 days in other clinical trials. * Known steroid IOP responder. * Taking medications that may affect vision, IOP, or ease of cataract surgery (e.g. Flomax, Glaucoma medications, etc.). * Acute or chronic disease or illness that would increase risk or confound study results(e.g. uncontrolled diabetes mellitus, immunocompromised, etc.). * Uncontrolled systemic or ocular disease. * Corneal abnormalities (e.g. stromal, epithelial, or endothelial dystrophies) * Pseudoexfoliation. * Ocular hypertension (\>or =20hg) or glaucomatous changes in the optic nerve.

Design outcomes

Primary

MeasureTime frameDescription
Intraocular Pressurethree monthMeasure the fluid pressure inside the eye.
Uncorrected and Best corrected Visual Acuitythree monthVision obtained with the best possible lens correction (Best corrected). Vision obtained without the use of glasses or contact lenses (Uncorrected).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026